The CFO of Iradimed Corp (IRMD) is Selling Shares


Today, the CFO of Iradimed Corp (NASDAQ: IRMD), Christopher Scott, sold shares of IRMD for $2.51M.

In addition to Christopher Scott, 2 other IRMD executives reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Based on Iradimed Corp’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $7.38 million and quarterly net profit of $1.35 million. In comparison, last year the company earned revenue of $5.52 million and had a net profit of $357.1K. IRMD’s market cap is $276.2M and the company has a P/E ratio of 123.86. Currently, Iradimed Corp has an average volume of 278.7K.

The insider sentiment on Iradimed Corp has been negative according to 28 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices and accessories and services. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts